Endpoints News ٢٥ نوفمبر ٢٠٢٥ Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial Novo Nordisk’s amycretin cuts body weight, blood sugar in Phase 2 diabetes trial المصدر